PAR14 COST MINIMIZATION ANALYSIS OF RITUXIMAB VERSUS...

PAR14 COST MINIMIZATION ANALYSIS OF RITUXIMAB VERSUS INFLIXIMAB, ADALIMUMAB AND ETANERCEPT FOR RHEUMATOID ARTHRITIS FROM A PAYER PERSPECTIVE IN BRAZIL

MG Saggia, EA Santos, V Nasciben
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
10
Year:
2007
Language:
english
DOI:
10.1016/s1098-3015(10)64929-7
File:
PDF, 70 KB
english, 2007
Conversion to is in progress
Conversion to is failed